Distalmotion key facts
as of Oct 2026- Developer of a surgical robotic technology designed to eliminate the complexity of surgical processes.
- Distalmotion is valued at approximately $2.0B as of Oct 2026 (last reported valuation).
- It has raised $401.5M; the latest was Later Stage VC ($150.0M) in Jan 2026.
- Notable investors include MedTech Innovator, Venture Kick, Kinled Holding, Ecole Polytechnique Federale de Lausanne, Johnson & Johnson JJDC — 16 tracked in total.
- Status: Privately Held (backing).
Distalmotion's last reported valuation, May 2023. Nothing priced has surfaced since.
- ·The complete investor list: 16 names
- ·Watch Distalmotion: the Monday email on marks, rounds and moves
Distalmotion funding rounds
No funding rounds for Distalmotion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Distalmotion
16+Distalmotion valuation
Distalmotion's last reported valuation was $2 billion in May 2023. No priced round, secondary trade or fund mark has surfaced since.
Distalmotion investors
16 investors are on record for Distalmotion, including MedTech Innovator, Venture Kick, Kinled Holding and Ecole Polytechnique Federale de Lausanne.
About Distalmotion
Developer of a surgical robotic technology designed to eliminate the complexity of surgical processes. The company's robotic device is used for dissection and suturing and performs a minimally invasive surgical procedure in the abdominal cavity by bridging surgical robotics with laparoscopy, enabling healthcare professionals to offer better healthcare services to their patients.
- Sector
- Healthcare
- HQ
- Lausanne, Switzerland
- Founded
- 2012
- Employees
- 227
- Website
- distalmotion.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.